{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:48:21Z","timestamp":1792601301673,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/pat.0b013e328353a24c","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T22:32:46Z","timestamp":1335306766000},"page":"318-324","source":"Crossref","is-referenced-by-count":42,"title":["Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma"],"prefix":"10.1016","volume":"44","author":[{"given":"Hui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-qun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e328353a24c_bib0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0010","first-page":"387","article-title":"Cancer and infection: estimates of the attributable fraction in 1990","volume":"6","author":"Pisani","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0015","doi-asserted-by":"crossref","first-page":"350","DOI":"10.6004\/jnccn.2009.0027","article-title":"NCCN clinical practice guidelines in oncology: hepatobiliary cancers","volume":"7","author":"Benson","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0020","first-page":"241","article-title":"Les acides nucleiques du plasma sanquin chez I\u2019homme","volume":"142","author":"Mandel","year":"1948","journal-title":"CR Acad Sci Paris"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0025","first-page":"181","article-title":"Circulating nucleic acids (CNAs) and cancer-a survey","volume":"1775","author":"Fleischhacker","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1006260319913","article-title":"Detection of circulating tumour DNA in the blood (plasma\/serum) of cancer patients","volume":"18","author":"Anker","year":"1999","journal-title":"Cancer Metastasis Rev"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0305-7372(02)00077-4","article-title":"Circulating DNA: a new diagnostic gold mine?","volume":"28","author":"Ziegler","year":"2002","journal-title":"Cancer Treat Rev"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0040","first-page":"3966","article-title":"Increased plasma DNA integrity in cancer patients","volume":"63","author":"Wang","year":"2003","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00006676-199807000-00012","article-title":"Cell-free DNA in human blood plasma: Length measurements in patients with pancreatic cancer and healthy controls","volume":"17","author":"Giacona","year":"1998","journal-title":"Pancreas"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4161\/cbt.4.2.1508","article-title":"Overview of cell death signaling pathways","volume":"4","author":"Jin","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0055","first-page":"646","article-title":"Free DNA in the serum of cancer patients and the effect of therapy","volume":"37","author":"Leon","year":"1977","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1245\/aso.2002.9.1.71","article-title":"Persistence of tumor DNA in plasma ofbreast cancer patients after mastectomy","volume":"9","author":"Silva","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3835(95)03742-F","article-title":"Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours","volume":"91","author":"Fournie","year":"1995","journal-title":"Cancer Lett"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0070","first-page":"4675","article-title":"Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients","volume":"61","author":"Sozzi","year":"2001","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2003.11.023","article-title":"Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer","volume":"205","author":"Jung","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0080","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/jnci\/94.22.1697","article-title":"Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer","volume":"94","author":"Chang","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0085","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2003.02.006","article-title":"Quantification of free circulating DNA as a diagnostic marker in lung cancer","volume":"21","author":"Sozzi","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0090","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2004.11.123","article-title":"Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy","volume":"22","author":"Gautschi","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0095","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0100","series-title":"TNM Classification of Malignant Tumours.","first-page":"131","author":"Sobin","year":"2002"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0105","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1373\/clinchem.2008.110122","article-title":"Comparison of 7 methods for extracting cell-free DNA from serum samples of colorectal cancer patients","volume":"55","author":"Fong","year":"2009","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cca.2009.02.018","article-title":"Optimizing the yield and utility of circulating cell-free DNA from plasma and serum","volume":"404","author":"Xue","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0115","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/sj.bjc.6601609","article-title":"Quantitation of circulating DNA in the serum ofbreast cancer patients by real-time PCR","volume":"90","author":"Gal","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1349-7006.2008.01021.x","article-title":"Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy","volume":"100","author":"Cheng","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0125","first-page":"421","article-title":"Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases","volume":"22","author":"Thijssen","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00535-005-1566-3","article-title":"Updated treatment approach to hepatocellular carcinoma","volume":"40","author":"Llovet","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1196\/annals.1318.003","article-title":"Challenges for biomarkers in cancer detection","volume":"1022","author":"Wagner","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1196\/annals.1368.040","article-title":"Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation","volume":"1075","author":"Umetani","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0145","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/clinchem\/47.9.1607","article-title":"Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma","volume":"47","author":"Chiu","year":"2001","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0150","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1373\/49.3.525","article-title":"Effects of blood-processing protocols on cell-free DNA quantification in plasma","volume":"49","author":"Swinkels","year":"2003","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0155","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/clinchem\/44.10.2201","article-title":"Use of real-time quantitative PCR to compare DNA isolation methods","volume":"44","author":"de Kok","year":"1998","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0160","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.1537-2995.2001.41020276.x","article-title":"Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma","volume":"41","author":"Lee","year":"2001","journal-title":"Transfusion"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinchem\/48.3.421","article-title":"Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation","volume":"48","author":"Lui","year":"2002","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1373\/clinchem.2004.039263","article-title":"Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies","volume":"51","author":"Herrera","year":"2005","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12253-011-9438-z","article-title":"Quantitation of plasma circulating DNA using quantitative PCR for the detection of hepatocellular carcinoma","volume":"18","author":"Huang","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0180","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00432-005-0049-5","article-title":"The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma","volume":"132","author":"Ren","year":"2006","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/CCLM.2006.003","article-title":"Plasma cell-free DNA as an indicator of severity of injury in burn patients","volume":"44","author":"Chiu","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0190","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1097\/01.CCM.0000074719.40109.95","article-title":"Elevated nucleosome levels in systemic inflammation and sepsis","volume":"31","author":"Zeerleder","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0195","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1373\/49.8.1286","article-title":"Time course of early and late changes in plasma DNA in trauma patients","volume":"49","author":"Lam","year":"2003","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.resuscitation.2005.05.021","article-title":"Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24 h of symptom onset","volume":"68","author":"Lam","year":"2006","journal-title":"Resuscitation"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cca.2005.12.021","article-title":"Plasma beta-globin DNA as a prognosticmarker in chest pain patients","volume":"368","author":"Rainer","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1368.043","article-title":"Nucleosomal DNA fragments in autoimmune diseases","volume":"1075","author":"Holdenrieder","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0215","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/1097-0142(19830601)51:11<2116::AID-CNCR2820511127>3.0.CO;2-S","article-title":"Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease","volume":"51","author":"Shapiro","year":"1983","journal-title":"Cancer"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0220","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1097-0215(20010320)95:2<114::AID-IJC1020>3.0.CO;2-Q","article-title":"Nucleosomes in serum of patients with benign and malignant diseases","volume":"95","author":"Holdenrieder","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1097\/PAT.0b013e328353a24c_bib0225","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2006.05.9493","article-title":"Prediction ofbreast tumor progression by integrity of free circulating DNA in serum","volume":"24","author":"Umetani","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516325181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516325181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T14:49:50Z","timestamp":1594046990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516325181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0031302516325181"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e328353a24c","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}